Literature DB >> 31991201

Prosthechea karwinskii, an orchid used as traditional medicine, exerts anti-inflammatory activity and inhibits ROS.

Gabriela Soledad Barragán-Zarate1, Luicita Lagunez-Rivera2, Rodolfo Solano3, Elizabeth Arlen Pineda-Peña4, Arizai Yolia Landa-Juárez5, Aracely Evangelina Chávez-Piña6, Candy Carranza-Álvarez7, Diego Manuel Hernández-Benavides8.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Prosthechea karwinskii (Mart.) J.M.H. Shaw is a Mexican orchid used in traditional medicine by some indigenous communities to treat issues related to inflammation (cough, wounds, burns, and diabetes). Pharmacological research of this orchid could validate its therapeutic uses and demonstrate its potential for treating other health conditions of high prevalence in Mexico, including those associated with oxidative stress such as diabetes, cancer, atherosclerosis, and hypertension as well as inflammation. AIM OF THE STUDY: The leaf extract from P. karwinskii was examined to identify its compounds and elucidate its inhibitory effect on reactive oxygen species as well as its anti-inflammatory activity and gastroprotective effects in an animal model.
MATERIALS AND METHODS: Compounds were identified via ultra-high-performance liquid chromatography coupled with electrospray ionization with quadrupole time of flight-mass spectrometry. Inhibition of reactive oxygen species was determined ex vivo in peripheral blood mononuclear cells with 2',7'-dichlorodihydrofluorescein diacetate. The anti-inflammatory activity was assessed using a carrageenan-induced paw edema model in Wistar rats; nitric oxide and tumor necrosis factor alpha levels were quantified. The gastroprotective effect was evaluated in Wistar rats with indomethacin-induced gastric injury.
RESULTS: Nine compounds were identified in the P. karwinskii leaf extract. Most compounds, such as quinic acid, malic acid, neochlorogenic acid, chlorogenic acid, rutin, embelin, pinellic acid, and azelaic acid, were reported to exhibit antioxidant and/or anti-inflammatory activity. The extract was also found to inhibit reactive oxygen species in the ex vivo model. Unlike other anti-inflammatory drugs, the extract exerted a dual effect: anti-inflammatory activity and protection of the gastric mucosa. The results showed that the extract could significantly inhibit the release of nitric oxide without a dose-response relationship.
CONCLUSION: P. karwinskii leaf extract inhibited reactive oxygen species and exerted an anti-inflammatory effect. Moreover, this extract did not induce gastric damage in the animals. The bioactivity of the species was found to support its use in traditional medicine. This orchid could be used to treat inflammatory diseases without causing the side effects associated with nonsteroidal anti-inflammatory drugs. It can also be employed to treat other pathological conditions associated with oxidative stress. The findings herein form the basis for the future discovery of natural products that may serve as safe alternative therapies for inflammatory disorders.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; DCFH-DA; Gastroprotection; Orchidaceae; Oxidative stress; UPLC-ESI-qTOF-MS/MS

Mesh:

Substances:

Year:  2020        PMID: 31991201     DOI: 10.1016/j.jep.2020.112632

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  2 in total

1.  Extract of Pinus densiflora needles suppresses acute inflammation by regulating inflammatory mediators in RAW264.7 macrophages and mice.

Authors:  Seul-Yong Jeong; Won Seok Choi; Oh Seong Kwon; Jong Seok Lee; Su Young Son; Choong Hwan Lee; Sarah Lee; Jin Yong Song; Yeon Jin Lee; Ji-Yun Lee
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Validation of the traditional medicinal use of a Mexican endemic orchid (Prosthechea karwinskii) through UPLC-ESI-qTOF-MS/MS characterization of its bioactive compounds.

Authors:  Gabriela Soledad Barragán-Zarate; Luicita Lagunez-Rivera; Rodolfo Solano; Candy Carranza-Álvarez; Diego Manuel Hernández-Benavides; Gerard Vilarem
Journal:  Heliyon       Date:  2022-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.